Αρχική World News England: Smoking responsible for twice as many cancers in most deprived groups

England: Smoking responsible for twice as many cancers in most deprived groups

Cigarette smoke.

Smoking is responsible for nearly twice as many cancer cases in lower income groups compared to higher income groups, according to new estimates by Cancer Research UK.

Over 11,000 cases of cancer were linked to smoking in the lowest income group, compared to around 6,000 in the highest.

Decades of glitzy packaging and marketing by the tobacco industry and targeting vulnerable groups has led us here…. [but] public health and prevention services play a vital role in tackling these health inequalities.

– Professor Linda Bauld, public health expert

Deprivation and smoking

More than 27,000 cases of cancer a year in England are associated with poverty, or deprivation, according to Cancer Research UK estimates.

People living in more deprived areas are 2.5 times more likely to smoke than those in least deprived and find it harder to quit, contributing to major health inequalities.

Experts think this is likely to be down to a mix of factors such as exposure to cigarettes, tobacco industry targeting, housing and income pressures, access to health and social care, information and education.

The study found that, of the 27,000 cases of cancer caused by deprivation, if smoking inequalities were removed and smoking rates were the same for everyone, around 5,500 of these cases could have been prevented each year in England.

Public health expert, Professor Linda Bauld, believes public health services have a vital role to play in combatting this stark inequality.

“It’s not a case of just telling people to stop smoking – going cold turkey doesn’t work for everyone. People who smoke shouldn’t be blamed but need support and the right tools to help them quit.”

She said: “Smoking has accounted for more deaths than COVID-19 in the past year. Public health and prevention services play a vital role in tackling health inequalities as well as improving health and wellbeing across England. This has come into even sharper focus since the pandemic, which has exposed where investment in these services has fallen behind.”

Achieving smoke-free

Smoking has long been the biggest preventable cause of cancer and death worldwide and is known to cause at least 15 different types of cancer, not just lung cancer.

The Government has set a goal of England becoming smoke-free by 2030, but there is a clear socio-economic divide that needs to be addressed. The most deprived groups are not on track to achieve this goal until the mid-2040s, while the least deprived are expected to achieve it in 2025.

But despite this, Stop Smoking Services, which give smokers the best chance of quitting, have continuously had their funding cut, and public health campaigns, which motivate people to stop smoking, have been axed.

Cancer Research UK’s chief executive, Michelle Mitchell believes this needs to be addressed. “Funding for tobacco control activities in England has been significantly cut in recent years, which will undermine the Government’s Smokefree 2030 goal unless this is urgently reversed.”

‘Funds without interference’

Only last week, Philip Morris International, the maker of Malboro cigarettes, announced they wanted to stop selling cigarettes in the next 10 years in the UK and expand in the health care business.

In response, Mitchell said: “We’ve heard these empty promises from the tobacco industry before and we’re concerned this move is part of an attempt by Big Tobacco to position itself as part of the solution to a smoke-free UK, all the while continuing to promote and sell lethal cigarettes here and globally.

“We know from our work supporting low and middle-income countries in the fight against tobacco industry interference, that Philip Morris’s actions globally don’t match up with their smoke-free world rhetoric.”

Mitchell called for more efforts to persuade people not to smoke, but said the tobacco industry should be made to contribute to the cost.

The charity believes one solution could be a Smokefree Fund – making tobacco companies cover the costs of the damage caused by smoking but without their involvement on how the money is spent – would be a much-needed new source of funding for tobacco control to help people stop smoking.

It would also mean more of the public health budget would be available for use in other important areas of public health and vitally reduce the cost of smoking related illnesses to the NHS in the future.

“It’s very concerning that smoking causes more cancer cases in more deprived groups. The upcoming tobacco control plan for England is a key opportunity for the Government to tackle smoking rates as well as the long-standing, unacceptable health inequalities that exist across the country,” said Mitchell.

“But this can only be achieved if there is sufficient additional investment into tobacco control. A Smokefree Fund – using tobacco industry funds, but without industry interference – could pay for the comprehensive measures needed to reduce smoking rates across all socio-economic groups.”

More on this topic

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Making Important Decisions During Cancer: A Survivor’s Story

Bethany Hart lives with her husband Kevin, sons, and 3 dogs in the suburbs of Indianapolis, Indiana. She is a survivor of small cell neuroendocrine cervical cancer....

Adjuvant Immunotherapy Approved for Some Patients with Lung Cancer

October 26, 2021, by NCI Staff Atezolizumab (Tecentriq) is approved as an additional treatment for some patients with stage II to IIIA (pictured) non-small cell...

Cure Probability Models for Evaluation of Patients with a Previous Cancer Diagnosis for Solid Organ Transplantation

Findings from a first study that applied a formal statistical framework to inform the evaluation of transplant candidates with a previous cancer diagnosis were...

Teacher Reads To Students One Day After Having Brain Surgery

Meucci - who had her surgery on a Wednesday - was going live from her intensive care unit hospital room that very next Thursday...

6 things you need to know about cervical screening

This article was originally published in 2017 during Cervical Screening Awareness Week. It has now been reviewed and updated. Cervical screening, also known as the...

EMA Recommends Granting a Marketing Authorisation for Sacituzumab Govitecan

On 14 October 2021, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...